Developer docs
API playgroundTry for free, no card

Search company profiles

Resonic NDT

Full company profile

uuid0057fhr

Namestring
Resonic NDT
Legal namestring
Soliton, Inc.
Websiteurl
resonic.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Resonic NDT is the commercial brand for a non-invasive medical aesthetic device that targets the appearance of cellulite, owned and developed by Soliton, Inc. — a wholly-owned subsidiary of AbbVie Inc. operating within its Allergan Aesthetics division. The company's sole commercial offering is the RESONIC™ device, marketed to US-based dermatologists, medical aesthetic practices, and licensed aestheticians who deploy it as an in-office treatment for female patients affected by cellulite (a condition the company cites as affecting 9 of 10 US women). Resonic functions as a B2B2C medical device brand rather than a treatment provider: it sells hardware to practitioners and uses a consumer-facing website to drive patient demand toward those practitioners.

The device is built on the proprietary Rapid Acoustic Pulse (RAP)™ platform, which delivers high-frequency sound waves at 50–100 pulses per second to perform what the company terms "acoustic subcision" — a mechanical process that physically breaks apart the stiffened connective bands (septa) beneath the skin that cause cellulite dimpling, without cutting the skin, using needles, or administering anesthesia. Each treatment is a single session lasting 45–60 minutes, and the company cites a 93% patient satisfaction rate at 12 weeks and maintained satisfaction at 52 weeks from a clinical study.

Resonic monetizes through hardware device sales to healthcare providers, with financing options offered to practices that lower the upfront capital barrier. Go-to-market is a dual motion: enterprise field sales to providers (via a Healthcare Professional portal that captures NPI numbers and clinical credentials) paired with direct-to-consumer marketing on resonic.com that funnels prospective patients toward acquiring providers. The brand is promoted across Allergan Aesthetics' social channels (LinkedIn, Instagram, Facebook) and clinical credibility is anchored by a small set of named dermatologist endorsers. Distribution is direct-to-provider within the USA only, with no disclosed international operations, no app or software product surface, and no disclosed revenue or installed base.

Short descriptiontext

Resonic NDT is the commercial brand for the RESONIC™ medical device, which uses proprietary Rapid Acoustic Pulse (RAP)™ acoustic subcision technology to non-invasively reduce cellulite. It is sold by Soliton, Inc. (an AbbVie subsidiary) through Allergan Aesthetics to US dermatologists and aesthetic practices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
cellulite reduction treatment, acoustic pulse technology, aesthetic medical devices, non-invasive body contouring, dermatology treatment systems
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Aesthetic Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

RESONIC sells its Rapid Acoustic Pulse device to healthcare providers (dermatologists, aesthetic practices) who use it to treat patients. The website mentions financing options available for practices, indicating device sales as the primary revenue stream.

resonic.com
2Treatment Services Revenue
TypeHardware Sales
Description

Healthcare providers purchase the device and offer treatments to patients, generating revenue per treatment session. The company facilitates this through HCP partnerships and direct-to-consumer marketing to drive patient demand.

resonic.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Resonic sells the RESONIC™ medical aesthetic device, which uses proprietary Rapid Acoustic Pulse (RAP)™ technology to deliver high-frequency sound waves (50–100 cycles per second) that perform acoustic subcision to break apart the septa bands causing cellulite. The device is sold to dermatologists, aesthetic practices, and licensed aestheticians in the United States, who in turn use it to offer non-invasive, single-session cellulite reduction treatments to patients without surgery, needles, anesthesia, or downtime.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

RESONIC™ is a single unified medical device product for aesthetic/cosmetic treatment. The core offering consists of the RESONIC™ device itself, which is powered by the proprietary Rapid Acoustic Pulse (RAP)™ technology. This technology platform enables non-invasive cellulitis reduction treatment through acoustic subcision. The product is offered as one integrated system with no separate modules or add-ons mentioned.

Product and service1 record
1RESONIC™ Cellulite Reduction Device
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Soliton, Inc. is the developer and original company behind the RESONIC technology. It was acquired by AbbVie and operates as a subsidiary under Allergan Aesthetics. RESONIC and its design are trademarks of Soliton, Inc., an AbbVie company.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Sciton, Inc.
TypeDirect peer
Description

Sciton is a privately-held US manufacturer of laser and light-based aesthetic and medical platforms (BBL, Halo, Joule). It competes with RESONIC for the same dermatologist and plastic surgeon customers with non-invasive aesthetic technology.

TypeDirect peer
Description

Lumenis is a global energy-based medical device company focused on aesthetic, surgical, and ophthalmic applications. Its aesthetic portfolio (e.g., ResurFX, M22) addresses body and skin treatments, making it a comparable direct competitor in the non-invasive device category.

TypeDirect peer
Description

InMode is a leading energy-based aesthetic medical device company offering platforms for body contouring, skin tightening, and cellulite reduction (e.g., BodyTite, Morpheus8). It is highly comparable to RESONIC as both target dermatologists and aesthetic practices with non-invasive body contouring solutions sold via direct enterprise sales.

4BTL Industries
TypeDirect peer
Description

BTL Industries (now backed by Bain Capital) makes non-invasive body contouring and aesthetic devices such as Emsculpt, Emtone, and Exilis. Emtone in particular is a direct competitor for cellulite treatment, making BTL one of the closest direct peers to RESONIC's acoustic subcision device.

5Candela Medical
TypeDirect peer
Description

Candela Medical is a global aesthetic device company producing laser and energy-based systems (GentleLase, Vbeam, Nordlys) for body and skin treatments. It competes in the same providers/segments as RESONIC with non-invasive aesthetic procedures.

TypeDirect peer
Description

Cutera develops and markets aesthetic laser and energy-based devices (TruSculpt, AviClear, excel V) for body sculpting, skin rejuvenation, and dermatology. It is a direct competitor to RESONIC in the device-based non-invasive aesthetic treatment space, targeting the same HCP customer base.

TypeDirect peer
Description

Venus Concept manufactures aesthetic devices (Venus Bliss, Venus Legacy, Venus Versa) for body contouring, cellulite reduction, and skin rejuvenation. It is a direct competitor to RESONIC with a similar go-to-market targeting aesthetic practices and medspas.

TypeDirect peer
Description

Cynosure, acquired by Hologic, is an aesthetic medical device manufacturer offering body contouring (TempSure, SculpSure) and skin treatment systems. It directly competes with RESONIC in the dermatology/aesthetic practitioner channel with non-invasive energy-based platforms.

TypeDirect peer
Description

Alma Lasers (a Sisram Medical company) is a leading global provider of energy-based aesthetic devices, including platforms for body contouring and skin tightening (Accent, Alma Harmony). It is comparable to RESONIC as a direct competitor selling non-invasive devices to dermatologists and aesthetic practices.

TypeDirect peer
Description

Solta Medical, a division of Bausch Health, manufactures the Thermage, Fraxel, and Clear + Brilliant systems for skin tightening and rejuvenation. It overlaps with RESONIC in selling premium aesthetic devices to dermatologists and plastic surgeons, and competes in the body/skin treatment category.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Resonic NDT

Medical Aesthetic Devicesresonic.com

Resonic NDT is the commercial brand for the RESONIC™ medical device, which uses proprietary Rapid Acoustic Pulse (RAP)™ acoustic subcision technology to non-invasively reduce cellulite. It is sold by Soliton, Inc. (an AbbVie subsidiary) through Allergan Aesthetics to US dermatologists and aesthetic practices.

What Resonic NDT does

Resonic NDT is the commercial brand for a non-invasive medical aesthetic device that targets the appearance of cellulite, owned and developed by Soliton, Inc. — a wholly-owned subsidiary of AbbVie Inc. operating within its Allergan Aesthetics division. The company's sole commercial offering is the RESONIC™ device, marketed to US-based dermatologists, medical aesthetic practices, and licensed aestheticians who deploy it as an in-office treatment for female patients affected by cellulite (a condition the company cites as affecting 9 of 10 US women). Resonic functions as a B2B2C medical device brand rather than a treatment provider: it sells hardware to practitioners and uses a consumer-facing website to drive patient demand toward those practitioners.

The device is built on the proprietary Rapid Acoustic Pulse (RAP)™ platform, which delivers high-frequency sound waves at 50–100 pulses per second to perform what the company terms "acoustic subcision" — a mechanical process that physically breaks apart the stiffened connective bands (septa) beneath the skin that cause cellulite dimpling, without cutting the skin, using needles, or administering anesthesia. Each treatment is a single session lasting 45–60 minutes, and the company cites a 93% patient satisfaction rate at 12 weeks and maintained satisfaction at 52 weeks from a clinical study.

Resonic monetizes through hardware device sales to healthcare providers, with financing options offered to practices that lower the upfront capital barrier. Go-to-market is a dual motion: enterprise field sales to providers (via a Healthcare Professional portal that captures NPI numbers and clinical credentials) paired with direct-to-consumer marketing on resonic.com that funnels prospective patients toward acquiring providers. The brand is promoted across Allergan Aesthetics' social channels (LinkedIn, Instagram, Facebook) and clinical credibility is anchored by a small set of named dermatologist endorsers. Distribution is direct-to-provider within the USA only, with no disclosed international operations, no app or software product surface, and no disclosed revenue or installed base.

Resonic NDT firmographics

Firmographics
Name
Resonic NDT
Legal name
Soliton, Inc.
Website
https://resonic.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Resonic NDT is the commercial brand for the RESONIC™ medical device, which uses proprietary Rapid Acoustic Pulse (RAP)™ acoustic subcision technology to non-invasively reduce cellulite. It is sold by Soliton, Inc. (an AbbVie subsidiary) through Allergan Aesthetics to US dermatologists and aesthetic practices.
Ownership category
akta.pro rank

Resonic NDT business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Medical Device Sales: RESONIC sells its Rapid Acoustic Pulse device to healthcare providers (dermatologists, aesthetic practices) who use it to treat patients. The website mentions financing options available for practices, indicating device sales as the primary revenue stream.
  2. Treatment Services Revenue: Healthcare providers purchase the device and offer treatments to patients, generating revenue per treatment session. The company facilitates this through HCP partnerships and direct-to-consumer marketing to drive patient demand.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Resonic NDT product offering

Product offering

Core offering

Resonic sells the RESONIC™ medical aesthetic device, which uses proprietary Rapid Acoustic Pulse (RAP)™ technology to deliver high-frequency sound waves (50–100 cycles per second) that perform acoustic subcision to break apart the septa bands causing cellulite. The device is sold to dermatologists, aesthetic practices, and licensed aestheticians in the United States, who in turn use it to offer non-invasive, single-session cellulite reduction treatments to patients without surgery, needles, anesthesia, or downtime.

Product overview

RESONIC™ is a single unified medical device product for aesthetic/cosmetic treatment. The core offering consists of the RESONIC™ device itself, which is powered by the proprietary Rapid Acoustic Pulse (RAP)™ technology. This technology platform enables non-invasive cellulitis reduction treatment through acoustic subcision. The product is offered as one integrated system with no separate modules or add-ons mentioned.

Differentiator

Problem solved

Functional benefit

Products and services

  • RESONIC™ Cellulite Reduction Device

Companies that use Resonic NDT

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Resonic NDT technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Resonic NDT partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Soliton, Inc. (AbbVie)coreOthersSoliton, Inc. is the developer and original company behind the RESONIC technology. It was acquired by AbbVie and operates as a subsidiary under Allergan Aesthetics. RESONIC and its design are trademarks of Soliton, Inc., an AbbVie company.

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Resonic NDT competitors and assessment

Company assessment

Direct peers

  • Sciton, Inc. Sciton is a privately-held US manufacturer of laser and light-based aesthetic and medical platforms (BBL, Halo, Joule). It competes with RESONIC for the same dermatologist and plastic surgeon customers with non-invasive aesthetic technology.
  • Lumenis Be Ltd. Lumenis is a global energy-based medical device company focused on aesthetic, surgical, and ophthalmic applications. Its aesthetic portfolio (e.g., ResurFX, M22) addresses body and skin treatments, making it a comparable direct competitor in the non-invasive device category.
  • InMode Ltd. InMode is a leading energy-based aesthetic medical device company offering platforms for body contouring, skin tightening, and cellulite reduction (e.g., BodyTite, Morpheus8). It is highly comparable to RESONIC as both target dermatologists and aesthetic practices with non-invasive body contouring solutions sold via direct enterprise sales.
  • BTL Industries: BTL Industries (now backed by Bain Capital) makes non-invasive body contouring and aesthetic devices such as Emsculpt, Emtone, and Exilis. Emtone in particular is a direct competitor for cellulite treatment, making BTL one of the closest direct peers to RESONIC's acoustic subcision device.
  • Candela Medical: Candela Medical is a global aesthetic device company producing laser and energy-based systems (GentleLase, Vbeam, Nordlys) for body and skin treatments. It competes in the same providers/segments as RESONIC with non-invasive aesthetic procedures.
  • Cutera, Inc. Cutera develops and markets aesthetic laser and energy-based devices (TruSculpt, AviClear, excel V) for body sculpting, skin rejuvenation, and dermatology. It is a direct competitor to RESONIC in the device-based non-invasive aesthetic treatment space, targeting the same HCP customer base.
  • Venus Concept Inc. Venus Concept manufactures aesthetic devices (Venus Bliss, Venus Legacy, Venus Versa) for body contouring, cellulite reduction, and skin rejuvenation. It is a direct competitor to RESONIC with a similar go-to-market targeting aesthetic practices and medspas.
  • Cynosure (Hologic): Cynosure, acquired by Hologic, is an aesthetic medical device manufacturer offering body contouring (TempSure, SculpSure) and skin treatment systems. It directly competes with RESONIC in the dermatology/aesthetic practitioner channel with non-invasive energy-based platforms.
  • Alma Lasers: Alma Lasers (a Sisram Medical company) is a leading global provider of energy-based aesthetic devices, including platforms for body contouring and skin tightening (Accent, Alma Harmony). It is comparable to RESONIC as a direct competitor selling non-invasive devices to dermatologists and aesthetic practices.
  • Solta Medical (Bausch Health): Solta Medical, a division of Bausch Health, manufactures the Thermage, Fraxel, and Clear + Brilliant systems for skin tightening and rejuvenation. It overlaps with RESONIC in selling premium aesthetic devices to dermatologists and plastic surgeons, and competes in the body/skin treatment category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

Resonic NDT social profiles

Digital presence

Resonic NDT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Resonic NDT leadership team

Management profile

Number of profiles

Resonic NDT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Resonic NDT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Resonic NDT

What does Resonic NDT do?

Resonic sells the RESONIC™ medical aesthetic device, which uses proprietary Rapid Acoustic Pulse (RAP)™ technology to deliver high-frequency sound waves (50–100 cycles per second) that perform acoustic subcision to break apart the septa bands causing cellulite. The device is sold to dermatologists, aesthetic practices, and licensed aestheticians in the United States, who in turn use it to offer non-invasive, single-session cellulite reduction treatments to patients without surgery, needles, anesthesia, or downtime.

Is Resonic NDT a public or private company?

Resonic NDT is a private company. It is classified as corporate owned and is currently operating.

When was Resonic NDT founded?

Resonic NDT was founded in -1. It employs 1 to 10 people.

How does Resonic NDT make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are treatment Services Revenue.

Who are Resonic NDT's main competitors?

Direct peers on record are Sciton, Inc., Lumenis Be Ltd., InMode Ltd., BTL Industries, Candela Medical, Cutera, Inc., Venus Concept Inc., Cynosure (Hologic), Alma Lasers and Solta Medical (Bausch Health).

Does Resonic NDT have an API?

No public API is recorded for Resonic NDT.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals